April 1- 4, 2024, Drug Discovery Chemistry

1) A Highly Differentiated Small Molecule Immune Checkpoint Inhibitor Dually Targeting PD-L1 And A2AR for Cancer Therapy
2) Targeting CBM, A Tri Protein Signalling Hub, by Inhibition Of MALT1 for the Treatment Of B- Cell Lymphomas